Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Minerva Neurosciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q4 2023
- Shares held
- 2.10M
- −315.7K (−13.1%) vs. Q4 2023
- Total value
- $5.42M
- −$9.44M (−63.5%) vs. Q4 2023
- New holders
- 2
- 8 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 10 | $26 | 0.00% | −55−84.6% | Reduced |
| Anchor Investment Management, LLC | 12 | $31 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 100 | $258 | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 100 | $258 | 0.00% | +100 | New |
| Bank of America Corp | 125 | $322 | 0.00% | −3−2.3% | Reduced |
| TFC Financial Management | 186 | $480 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 549 | $1.00K | 0.00% | +55+11.1% | Added |
| Russell Investments Group, Ltd. | 1,175 | $3.03K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,981 | $7.69K | 0.00% | +1,001+50.6% | Added |
| Tower Research Capital LLC (TRC) | 4,103 | $10.6K | 0.00% | +2,743+201.7% | Added |
| Morgan Stanley | 10,747 | $27.7K | 0.00% | +4,461+71.0% | Added |
| State Street Corp | 16,519 | $42.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 16,681 | $43.0K | 0.00% | +16,681 | New |
| Acadian Asset Management LLC | 17,423 | $44.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 23,086 | $59.6K | 0.00% | −1,900−7.6% | Reduced |
| Geode Capital Management, LLC | 52,592 | $135.7K | 0.00% | +500+1.0% | Added |
| BlackRock Inc. | 72,669 | $187.5K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 99,644 | $257.1K | 0.01% | +35,000+54.1% | Added |
| Renaissance Technologies LLC | 177,765 | $459.0K | 0.00% | +70,565+65.8% | Added |
| Vanguard Group Inc | 252,060 | $650.3K | 0.00% | +46,906+22.9% | Added |
| Federated Hermes, Inc. | 1,351,275 | $3.49M | 0.01% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −491,746−100.0% | Sold out |